Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Adam Bregman"'
Publikováno v:
BMC Nephrology, Vol 24, Iss 1, Pp 1-5 (2023)
Abstract Background Fibronectin glomerulopathy is a rare genetic nephropathy with only a few cases of post-transplant recurrence being reported previously. We highlight a case that was initially misdiagnosed and emphasize the importance of full immun
Externí odkaz:
https://doaj.org/article/766810a95ddd4b40bbc835deecf59033
Autor:
Rasha El-Rifai, Adam Bregman, Nattawat Klomjit, Richard Spong, Scott Jackson, Patrick H. Nachman, Samy Riad
Publikováno v:
Transplant International. 36
Using the Scientific Registry of Transplant Recipients, we examined the association between donor-recipient biologic relationship and long-term recipient and allograft survival among glomerulonephritis (GN) patients. Four GN types were studied: membr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b5ca9b50d897288020e60a268f215c1
https://doi.org/10.3389/ti.2023.11068
https://doi.org/10.3389/ti.2023.11068
Autor:
Lisa Dufficy, Michelle Feller, Isaiah Francis, Adam Bregman, Deborah Bonnes, Diana Jalal, Mark Yoder, Shannon Johnson-Bortolotto, Benjamin R. Griffin, Amanda Thomson, Darlene Tad-y, Sophia Ambruso, Christine King, Sarah Faubel, Anip Bansal, Chaorong Wu
Publikováno v:
Am J Kidney Dis
Rationale & Objective Clinical practice guidelines recommend delivering a continuous renal replacement therapy (CRRT) dose of 20 to 25 mL/kg/h. However, practice patterns nationwide are highly variable; this inconsistent prescribing may lead to error
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cd85ce029d2780a1bc4ce1cf11e5e5d
https://doi.org/10.1053/j.ajkd.2019.06.013
https://doi.org/10.1053/j.ajkd.2019.06.013